Found: 13
Select item for more details and to access through your institution.
ICH Q10 Pharmaceutical Quality System Guidance: Understanding Its Impact on Pharmaceutical Quality.
- Published in:
- AAPS Journal, 2021, v. 23, n. 6, p. 1, doi. 10.1208/s12248-021-00657-y
- By:
- Publication type:
- Article
Understanding Drug Delivery to the Brain Using Liposome-Based Strategies: Studies that Provide Mechanistic Insights Are Essential.
- Published in:
- AAPS Journal, 2021, v. 23, n. 6, p. 1, doi. 10.1208/s12248-021-00648-z
- By:
- Publication type:
- Article
Immunogenicity Risk Assessment for Multi-specific Therapeutics.
- Published in:
- AAPS Journal, 2021, v. 23, n. 6, p. 1, doi. 10.1208/s12248-021-00642-5
- By:
- Publication type:
- Article
Correction to: Considerations for Updates to ICH Q1 and Q5C Stability Guidelines: Embracing Current Technology and Risk Assessment Strategies.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Pharmacokinetics of Monoclonal Antibody and Antibody Fragments in the Mouse Eye Following Systemic Administration.
- Published in:
- AAPS Journal, 2021, v. 23, n. 6, p. 1, doi. 10.1208/s12248-021-00647-0
- By:
- Publication type:
- Article
A Systematic Approach for Liposome and Lipodisk Preclinical Formulation Development by Microfluidic Technology.
- Published in:
- AAPS Journal, 2021, v. 23, n. 6, p. 1, doi. 10.1208/s12248-021-00651-4
- By:
- Publication type:
- Article
Understanding Drug Delivery to the Brain Using Liposome-Based Strategies: Studies that Provide Mechanistic Insights Are Essential.
- Published in:
- AAPS Journal, 2021, v. 23, n. 6, p. 1, doi. 10.1208/s12248-021-00648-z
- By:
- Publication type:
- Article
Bioanalytical Challenges due to Prior Checkpoint Inhibitor Exposure: Interference and Mitigation in Drug Concentration and Immunogenicity Assays.
- Published in:
- AAPS Journal, 2021, v. 23, n. 6, p. 1, doi. 10.1208/s12248-021-00643-4
- By:
- Publication type:
- Article
Considerations for Updates to ICH Q1 and Q5C Stability Guidelines: Embracing Current Technology and Risk Assessment Strategies.
- Published in:
- AAPS Journal, 2021, v. 23, n. 6, p. 1, doi. 10.1208/s12248-021-00641-6
- By:
- Publication type:
- Article
Cluster Gauss–Newton and CellNOpt Parameter Estimation in a Small Protein Signaling Network of Vorinostat and Bortezomib Pharmacodynamics.
- Published in:
- AAPS Journal, 2021, v. 23, n. 6, p. 1, doi. 10.1208/s12248-021-00640-7
- By:
- Publication type:
- Article
Understanding In Vivo Dissolution of Immediate Release (IR) Solid Oral Drug Products Containing Weak Acid BCS Class 2 (BCS Class 2a) Drugs.
- Published in:
- AAPS Journal, 2021, v. 23, n. 6, p. 1, doi. 10.1208/s12248-021-00639-0
- By:
- Publication type:
- Article
Understanding Quality Paradigm Shifts in the Evolving Pharmaceutical Landscape: Perspectives from the USP Quality Advisory Group.
- Published in:
- AAPS Journal, 2021, v. 23, n. 6, p. 1, doi. 10.1208/s12248-021-00634-5
- By:
- Publication type:
- Article
Evaluation of the Humoral Response to Adeno-Associated Virus-Based Gene Therapy Modalities Using Total Antibody Assays.
- Published in:
- AAPS Journal, 2021, v. 23, n. 6, p. 1, doi. 10.1208/s12248-021-00628-3
- By:
- Publication type:
- Article